跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-GLICLAZIDE MR TABLET 30MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-GLICLAZIDE MR TABLET 30MG
Approved
THERAPEUTIC
APO-GLICLAZIDE MR TABLET 30MG
APOTEX INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 25, 2012
Approval ID
b124a99a0bb4af14
Company
APOTEX INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
b124a99a0bb4af14
Drug Name
APO-GLICLAZIDE MR TABLET 30MG
Product Name
APO-GLICLAZIDE MR TABLET 30MG
Approval Number
SIN14258P
Approval Date
2012-10-25
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
A10BB09
Atc Item Name
gliclazide
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Gliclazide
30.0mg
GLICLAZIDE
30 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 25, 2012
Approval ID
b124a99a0bb4af14
Type
Therapeutic
Back to HSA Approvals